Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05520866 · ClinicalTrials.gov registry record · NA
PrehabPal: A Digital Tool to Help Older Adults Prepare for Cancer Surgery
A NA study of Colon Cancer, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 132
- Enrollment target
- 3
- Study locations
NCT05520866: Recruiting NA study of Colon Cancer, sponsored by University of California, San Francisco.
NCT05520866 is a NA study of Colon Cancer that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 132 participants, below the 4,455-participant average among 97 other Colon Cancer trials with a reported enrollment target (97% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05520866, a NA study of Colon Cancer, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 132 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a multi-center, randomized trial investigating the use of PrehabPal web app versus a written surgery prehabilitation instructions among individuals aged 65 years and older preparing for colon cancer surgery. PrehabPal is a web app designed with, and for, older adults preparing for surgery at University of California, San Francisco (UCSF). This app has the potential to fill a crucial clinical gap for older cancer patients by designing an individualized prehabilitation program and providing prehabilitation coaching.
Primary Outcome
The proportion of days before surgery engaged in prehabilitation between subjects randomized to the PrehabPal Web App and written prehabilitation materials using logistic regression. Since sites may not balance, all relevant sociodemographic and clinical characteristics of the subjects may be included in the models which will include other factors that are not balanced between the sites.
Conditions Studied
Interventions
- BEHAVIORAL PrehabPal
Study Locations (3)
California
- Stanford University - Palo Alto
- University of California, San Francisco - San Francisco
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2023-03-14 |
| Est. Completion | 2026-04-15 |
| Phase | NA |
What NCT05520866 shows while recruiting
NCT05520866 is an interventional study that assigns participants to a tested intervention. The registered 132 participants enrollment target is mid-sized for trials with a published cap, below the 4,455-participant average among 97 other Colon Cancer trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Colon Cancer appearing as the primary indexed condition, and to 1 intervention - of which PrehabPal is the first listed.
NCT05520866 reports a single indexed study location in California, Texas.
Frequently Asked Questions
What is clinical trial NCT05520866 about?
NCT05520866 is a clinical study titled "PrehabPal: A Digital Tool to Help Older Adults Prepare for Cancer Surgery". This is a multi-center, randomized trial investigating the use of PrehabPal web app versus a written surgery prehabilitation instructions among individuals aged 65 years and older preparing for colon cancer surgery. PrehabPal is a web app designed with, and for, older adults preparing for surgery at...
What is the current status of trial NCT05520866?
This trial is currently recruiting. It is a NA study. The enrollment target is 132 participants. The study started on 2023-03-14. Estimated completion is 2026-04-15.
What conditions does trial NCT05520866 study?
This clinical trial studies the following conditions: Colon Cancer.
What interventions are being tested in trial NCT05520866?
The interventions under investigation include: PrehabPal (BEHAVIORAL).
Who is sponsoring clinical trial NCT05520866?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05520866 being conducted?
This trial has 3 study locations across California, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colon Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05520866's enrollment target sits among peer trials
132 44th of 97 higher than 54 of 97 other Colon Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colon Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
RECRUITING · NA
-
Resilience and Equity in Aging, Cancer, and Health (REACH)
RECRUITING · NA
-
Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit)
RECRUITING · NA
-
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
RECRUITING · NA
-
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01766297 · 132 participants · Phase 2
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
- NCT04002947 · 132 participants · Phase 2
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
- NCT04128189 · 132 participants · Phase 3
Shingrix in Renal Transplant Recipients
- NCT04199780 · 132 participants · NA
Effects of tDCS Combined With CBI on Postsurgical Pain
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI